Our analysis, based on several FDA trials and observed GLP-1 effects to date, suggests significant reductions in: Musculoskeletal interventions Sleep apnea severity Cardiometabolic complications Need for CPAP equipment Progression to joint replacement surgeries We expect these effects to accelerate in 2026
2006;291(3):R491-511
Small documentation failures including missing contemporaneous entries, incomplete batch records, and inconsistent procedures are showing up repeatedly in the enforcement record
Clinical evidence for semaglutide's effectiveness comes primarily from trials using doses of 1 mg, 1.7 mg, and 2.4 mg as maintenance levels
We conducted studies that assessed the effects of liraglutide and semaglutide in LDL receptor and ApoE knockout mice
Understanding your genetic profile does not predict which medication will work best, but can support a more personalized conversation about why certain formulations or dosing strategies may align with your biology and health goals